ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Control RFA Announcements

March 9, 1979

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

September 9, 2011

CMS Removes Obstacles for Contractors to Deny EPO Coverage for Cancer Anemia.

March 9, 2007

Peter Jones begins term as AACR president-elect. New directors elected.

April 2, 2004

In Brief: Six Major NIH Positions Now Open; M.D. Anderson Plans More Than $25 Million In Construction

August 21, 1981